Related Experiment Video
Updated: Jul 2, 2025

09:58
Lipidomics and Transcriptomics in Neurological Diseases
Published on: March 18, 2022
3.5K
Tribute to Dr. Judith G. Levin (1934-2023).
Karin Musier-Forsyth1, Alan Rein2, Eric O Freed3
1Department of Chemistry and Biochemistry, Center for Retrovirus Research, Center for RNA Biology, Ohio State University, Columbus, OH 43210, USA.
Viruses
|February 24, 2024
Summary
Dr. Judith G. Levin, a dedicated researcher, has passed away. Her contributions to the scientific community will be remembered.
Area of Science:
- Obituary
Background:
- Announcing the passing of Dr. Judith G. Levin.
Discussion:
- Dr. Levin was a respected figure in her field.
Key Insights:
- Her work has had a lasting impact.
Outlook:
- She will be deeply missed by colleagues and peers.
Related Concept Videos
Feedback Inhibition
53.9K
Biochemical reactions are occurring constantly in cells, converting starting substances to different products, usually with the help of enzymes that speed the reactions. Without enzymes, it would take far too long for most reactions to occur to be useful to the cell!
53.9K
Life Histories
17.9K
Overview
17.9K
Nature and Nurture
20.5K
Many human characteristics, like height, are shaped by both nature—in other words, by our genes—and by nurture, or our environment. For example, chronic stress during childhood inhibits the production of growth hormones and consequently reduces bone growth and height. Scientists estimate that 70-90% of variation in height is due to genetic differences among individuals, and 10-30% of variation in height is due to differences in the environments that individuals experience,...
20.5K
Genetic Lingo
102.8K
Overview
102.8K
Accessory Organs
69.3K
Accessory organs are those that participate in the digestion of food but do not come into direct contact with it like the mouth, stomach, or intestine do. Accessory organs secrete enzymes into the digestive tract to facilitate the breakdown of food.
69.3K
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K

